en · de · es · fr · pt
analytical-notes.peptides6823.com › Info › Structure And Receptor Pharmacology — Questions and Answers

Structure And Receptor Pharmacology — Questions and Answers

By Editorial Desk · published 2026-06-11 · last reviewed 2026-07-27 · Info

Albumin conjugation is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Last reviewed on 2026-07-27. Where a claim depends on a specific study, the study is described rather than over-claimed.

Structure And Receptor Pharmacology

Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.

Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.

Albumin Binding and Duration of Action

Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.

The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.

Cjc-1295 at a glance

PropertyValueNotes
Peptide classSynthetic GHRH analogueBuilt on a 29 residue sequence
Primary targetGHRH receptor (GHRHR)Class B G protein coupled receptor
Unconjugated half lifeMinutesLimited by protease degradation
Key modificationFour residue substitutionsPositions 2, 8, 15 and 27
Common synonymModified GRF(1-29)Usually denotes the form without DAC

Receptor Action and Pharmacokinetics

The attached maleimide group explains the unusual duration of the DAC version. After injection it reacts with the thiol of cysteine-34 on serum albumin, forming a stable covalent bond. The resulting conjugate is too large for rapid kidney filtration and is shielded from many peptidases. Reported half-lives for this form reach several days, whereas the version without the group is cleared in roughly half an hour. That gap is the main pharmacological difference between the two.

Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.

Related pages on this site

Background and Receptor Mechanism

At the pituitary, the peptide binds the growth hormone-releasing hormone receptor on somatotroph cells. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone. Somatostatin and other hypothalamic signals modulate this response. Negative feedback from insulin-like growth factor 1 also influences output. The same regulatory architecture operates with the native hormone. Whether the synthetic analog alters feedback dynamics over repeated exposure remains an open question. Most published receptor work uses cell models rather than intact human systems.

CJC-1295 is a synthetic peptide belonging to the growth hormone-releasing hormone analog family. It comprises twenty-nine amino acid residues derived from the N-terminal region of natural GHRH. The molecule incorporates several non-natural substitutions that increase resistance to enzymatic degradation. These modifications extend its activity compared with the native hormone fragment. Researchers use it to study pituitary growth hormone secretion in laboratory and clinical settings. This compound is distinct from native GHRH in its stability profile.

CJC-1295 Structure And Mechanism

Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.

CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.

Further detail

== Distribution == In humans, sarcosine is found at relatively low concentrations in the extracellular compartment, mitochondria, and peroxisomes. Tissues with measurable sarcosine concentrations include skeletal muscle and the prostate gland. Its cellular levels are tightly regulated by the balance between GNMT-mediated synthesis and SARDH/PIPOX-mediated catabolism.

=== Waxing and oiling === Historically, light waxing and oiling were the first treatments used in ancient times, providing a wetting effect, thereby enhancing the colour and lustre. This treatment is more or less acceptable by tradition, especially because treated turquoise is usually of a higher grade to begin with. Oiled and waxed stones are prone to "sweating" under even gentle heat or if exposed to too much sun, and they may develop a white surface film or bloom over time. (With some skill, oil and wax treatments can be restored.)

== Clinical significance == G6PD is remarkable for its genetic diversity. Many variants of G6PD, mostly produced from missense mutations, have been described with wide-ranging levels of enzyme activity and associated clinical symptoms. Two transcript variants encoding different isoforms have been found for this gene. Glucose-6-phosphate dehydrogenase deficiency is very common worldwide, and causes acute hemolytic anemia in the presence of simple infection, ingestion of fava beans, or reaction with certain medicines, antibiotics, antipyretics, and antimalarials.

One of the first memorials was the Tribute in Light, an installation of 88 searchlights at the footprints of the World Trade Center towers. In New York City, the World Trade Center Site Memorial Competition was held to design an appropriate memorial on the site. The winning design, Reflecting Absence, was selected in August 2006, and consists of a pair of reflecting pools in the footprints of the towers, surrounded by a list of the victims' names in an underground memorial space. The memorial was completed on the 10th anniversary of the attacks in 2011; a museum also opened on site in May 2014. The Sphere by the German sculptor Fritz Koenig is the world's largest bronze sculpture of modern times, and stood between the Twin Towers on the Austin J. Tobin Plaza from 1971 until the attacks. The sculpture, weighing more than 20 tons, was the only remaining work of art to be recovered largely intact from the ruins of the towers. Since then, the work of art, known in the U.S. as The Sphere, has been transformed into a symbolic monument of 9/11 commemoration. After being dismantled and stored near a hangar at John F. Kennedy International Airport, the sculpture was the subject of the 2001 documentary The Sphere by filmmaker Percy Adlon. In August 2017, the work was installed at Liberty Park, close to the new World Trade Center aerial and the 9/11 Memorial.

=== Other awards === Fenn received his Nobel Prize fairly late in his career. Prior to being honored by the Nobel Foundation, Fenn had received numerous other awards. Early in his career, Fenn's research was focused on molecular beams, leading him to be named an honorary president of the Sixth International Symposium on Molecular Beams in 1977, and the first fellow of the International Molecular Beam Symposium in 1985. In 1982, the Alexander von Humboldt Foundation presented him with their U.S. Senior Scientist Award. Fenn's work in mass spectrometry earned him another spate of awards later in his career. In 1992, the American Society for Mass Spectrometry presented him with their Award for Distinguished Contributions in Mass Spectrometry. The International Society of Mass Spectrometry honored him with the Thomson Medal in 2000, and in the same year the American Chemical Society presented him with the Award for Advancements in Chemical Instrumentation. He was awarded the Association of Biomolecular Resource Facilities Award for outstanding contributions to Biomolecular Technologies in 2002. In 2003, Fenn was honored by his alma mater with the Wilbur Cross Medal, the Yale Graduate School Alumni Association's highest honor. Fenn maintained numerous professional affiliations, including membership in the American Chemical Society, the American Society for Mass Spectrometry, Sigma Chi, the American Association of University Professors and the Alexander von Humboldt Association of America.

Sources: en.wikipedia.org

Background from the literature

==== Supermarkets ==== The third and final change to US food distribution in the first half of the 20th century involved the establishment of supermarkets. The Ford Motor Company performed the first experiment regarding the profitability of large-scale supermarkets after the end of World War I. Supermarkets officially began gaining prominence in the 1930s and steadily continued their growth into the post-WWII era.

=== Political === When the Allies achieved victory, Mexico was among the victors, despite only actively sending soldiers in the last year of the conflict. Therefore, the country was a founding member of the United Nations Organization, unlike the founding of the League of Nations in 1919, where it was not invited because it had remained neutral during the First World War. In the international arena, Mexico was more present, taking part in the Dumbarton Oaks Conference, the Treaty of San Francisco, the Bretton Woods Conference, and managed to have its initiative approved so that the dictatorship of Francisco Franco in Spain would not be recognized or admitted as a legitimate government before the UN, because it had been formed with the military aid of Nazi Germany and Fascist Italy.

Instead, the company offered to provide the medication free through its patient access program for hardship cases, though this option was described as much more restrictive. Oncologists criticized the decision as unprecedented, with Dr. Carmen de Ramon Ortiz of Geneva University Hospital noting that about 20% of follicular lymphoma patients require intensive treatment and that Lunsumio represents "a very innovative immunotherapy that stimulates the immune system, leading to high remission rates." Industry experts characterized the withdrawal as a form of healthcare rationing and a "canary in the coal mine," noting that only half of EU-approved medications are available in Switzerland. Some experts suggested the withdrawal reflected broader pressures from potential U.S. pricing reforms and trade uncertainties that could affect Roche's largest market, including potential tariff increases on pharmaceutical exports from 10% to up to 31%. The case was viewed by analysts as a potential precedent-setting "regulatory showdown" that could influence pharmaceutical pricing negotiations across the industry, particularly for rare disease treatments affecting small patient populations.

Amino acids are polymerised via peptide bonds to form a long backbone, with the different amino acid side chains protruding along it. In biological systems, proteins are produced during translation by a cell's ribosomes. Some organisms can also make short peptides by non-ribosomal peptide synthesis, which often use amino acids other than the encoded 22, and may be cyclised, modified and cross-linked.

Sources: en.wikipedia.org

Reference notes

Select patients with salvageable tissue Another element of clinical trial design is the use of imaging biomarkers to select patients that are likely to benefit from therapy. MRI and CT imaging methods that determine whether a patient is likely to have salvageable tissue have been used to great effect in clinical trials that showed the benefit of mechanical thrombectomy devices. These same methods can be applied to clinical trials for cerebroprotective drugs. Restore blood flow after protection so that protected tissue can survive long term If a drug protects the brain from reduced blood flow but then wears off before blood flow is normalized, then the long term effect of the drug may not be as great as it would be if the drug were paired with therapy to normalize blood flow. Pairing cerebroprotective drugs with approved methods to restore blood flow, such as tPA or mechanical thrombectomy, may increase their long term benefit.

A sixth position can reversibly bind oxygen by a coordinate covalent bond, completing the octahedral group of six ligands. This reversible bonding with oxygen is why hemoglobin is so useful for transporting oxygen around the body. Oxygen binds in an "end-on bent" geometry where one oxygen atom binds to Fe and the other protrudes at an angle. When oxygen is not bound, a very weakly bonded water molecule fills the site, forming a distorted octahedron. Even though carbon dioxide is carried by hemoglobin, it does not compete with oxygen for the iron-binding positions but is bound to the amine groups of the protein chains attached to the heme groups. The iron ion may be either in the ferrous Fe2+ or in the ferric Fe3+ state, but ferrihemoglobin (methemoglobin) (Fe3+) cannot bind oxygen. In binding, oxygen temporarily and reversibly oxidizes (Fe2+) to (Fe3+) while oxygen temporarily turns into the superoxide ion, thus iron must exist in the +2 oxidation state to bind oxygen. If superoxide ion associated to Fe3+ is protonated, the hemoglobin iron will remain oxidized and incapable of binding oxygen. In such cases, the enzyme methemoglobin reductase will be able to eventually reactivate methemoglobin by reducing the iron center. In adult humans, the most common hemoglobin type is a tetramer (which contains four subunit proteins) called hemoglobin A, consisting of two α and two β subunits non-covalently bound, each made of 141 and 146 amino acid residues, respectively. This is denoted as α2β2. The subunits are structurally similar and about the same size.

"Explaining the End of the Cold War: A New Historical Consensus?" Journal of Cold War Studies - Volume 4, Number 4, Fall 2002, pp. 60–92 in Project MUSE. Trachtenberg, Marc. "The Marshall Plan as Tragedy." Journal of Cold War Studies 2005 7(1): 135–140. ISSN 1520-3972 Fulltext: in Project MUSE. Walker, J. Samuel. "Historians and Cold War Origins: The New Consensus", in Gerald K. Haines and J. Samuel Walker, eds., American Foreign Relations: A Historiographical Review (1981), 207–236. Watry, David M. Diplomacy at the Brink: Eisenhower, Churchill, and Eden in the Cold War. Baton Rouge: Louisiana State University Press, 2014. ISBN 9780807157183. Westad, Odd Arne, ed. Reviewing the Cold War: Approaches, Interpretations, Theory (2000) essays by scholars. Westad, Odd Arne, "The New International History of the Cold War: Three (Possible) Paradigms," Diplomatic History, 2000, Vol. 24 in EBSCO. Westad, Odd Arne, ed. Reviewing the Cold War: Approaches, Interpretations, Theory (2000) excerpt and text search. Westad, Odd Arne, The Cold War: A World History, Basic Books, 2017. ISBN 0465054935. White, Timothy J. "Cold War Historiography: New Evidence Behind Traditional Typographies" International Social Science Review, (2000). Xia, Yafeng. "The Study of Cold War International History in China: A Review of the Last Twenty Years," Journal of Cold War Studies10#1 Winter 2008, pp. 81–115 in Project MUSE.

== Plot == A homeless Ren and Stimpy are caught again and sent to the dog pound, where they are sent to their imminent death. They are saved by an unnamed rich and senile lady (Granny) on the verge of death while a priest ordains them in a gas chamber. The duo feed themselves in Granny's limousine, grateful of their survival, when the woman decides to name them "Abraham" and "Levictus" which they reluctantly allow. The duo settle at their new home. Ren decides to shake hands with a dog he believes is a fellow pet. At first, Ren assumes the dog is sleeping and attempts to wake him up, only to discover that he is dead; Granny explains that the dog is a previous pet of hers named Ezekiel who died in his sleep, so his corpse was freeze-dried in a successful attempt of taxidermy. Suddenly, the duo are condemned by the lady for being apparently possessed, despite acting normal for their kind, as they are handed off to the lady's butler Mr. Hao, a stereotypical Chinese muscular man who beats them to a pulp. The duo, who cannot walk normally after the beating, are forced to eat literal rocks advertised as dog food. Ren breaks his teeth doing so while Stimpy chokes on it; Ren's unsuccessful attempt of the Heimlich maneuver is seen as a threat by Granny, who sprays Stimpy with water and forces him to spit. She sends them to a veterinarian who further harms them. The duo sleep in the living room when Granny forcibly moves them to the yard; they find that it is a cemetery for her pets.

Donald has supervised many students and postdocs, many of whom are now professors in reputed universities such as MIT, Carnegie-Mellon University, University of Washington, Seattle, University of Massachusetts Amherst, Dartmouth College, Duke University, Middlebury College and University of Toronto, and researchers at organizations such as NIAID, NIST, IBM, Sandia National Laboratories. Donald is the son of historian David Herbert Donald and historian and editor Aida DiPace Donald. MEMS Protein design NMR Protein Structure Kinodynamic planning Donald is the author of over 100 publications. A representative selection includes:

Sources: en.wikipedia.org

Frequently asked questions

Is CJC-1295 the same as modified GRF(1-29)?

The names are often used interchangeably in casual writing, but they are not strictly identical. Modified GRF(1-29) refers to the unconjugated analogue carrying only the four substitutions. The version sold as CJC-1295 with DAC includes the albumin binding linker and clears much more slowly.

What does the acronym DAC refer to?

DAC stands for drug affinity complex, a term describing the maleimidopropionic acid linker. This group forms a covalent bond with the cysteine residue on serum albumin after administration. The resulting adduct is what extends the circulating half life from minutes to days.

Does this peptide occur naturally in the body?

No. It is entirely synthetic and does not correspond to any known endogenous peptide. The design starts from human growth hormone releasing hormone and introduces deliberate substitutions. Any biological effect comes from mimicking the natural hormone at its receptor.

How does the reactive group attach to albumin?

A maleimide moiety reacts with the thiol of cysteine-34, forming a covalent bond. The reaction occurs in circulation without enzymatic catalysis.

Network